Antagonistic effects of the SRp30c protein and cryptic 5′ splice sites on the alternative splicing of the apoptotic regulator Bcl-x

被引:60
作者
Cloutier, Philippe [1 ]
Toutant, Johanne [1 ]
Shkreta, Lulzim [1 ]
Goekjian, Serge [2 ]
Revil, Timothee E. [1 ]
Chabot, Benoit [1 ]
机构
[1] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada
[2] Bishops Univ, Dept Biochem, Lennoxville, PQ J1M 1Z7, Canada
关键词
D O I
10.1074/jbc.M800353200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative 5' splice site selection allows Bcl-x to produce two isoforms with opposite effects on apoptosis. The pro-apoptotic Bcl-x(S) variant is up-regulated by ceramide and down-regulated by protein kinase C through specific cis-acting exonic elements, one of which is bound by SAP155. Splicing to the Bcl-xS 5' splice site is also enforced by heterogeneous nuclear ribonucleoprotein (hnRNP) F/H proteins and by Sam68 in cooperation with hnRNP A1. Here, we have characterized exon elements that influence splicing to the 5' splice site of the anti-apoptotic Bcl-x(L) isoform. Within a 86-nucleotide region (B3) located immediately upstream of the Bcl-x(L) donor site we have identified two elements (ML2 and AM2) that stimulate splicing to the Bcl-x(L) 5' splice site. SRp30c binds to these elements and can shift splicing to the 5' splice site of Bcl-xL in an ML2/AM2-dependent manner in vitro and in vivo. The B3 region also contains an element that represses the use of Bcl-x(L). This element is bound by U1 small nuclear ribonucleoprotein and contains two 5' splice sites that can be used when the Bcl-x(L) 5' splice site is mutated or the ML2/AM2 elements are deleted. Conversely, mutating the cryptic 5' splice sites stimulates splicing to the Bcl-x(L) site. Thus, SRp30c stimulates splicing to the downstream 5' splice site of Bcl-x(L), thereby attenuating the repressive effect of upstream U1 snRNP binding sites.
引用
收藏
页码:21315 / 21324
页数:10
相关论文
共 59 条
[1]  
Amundson SA, 2000, CANCER RES, V60, P6101
[2]   Mechanisms of alternative pre-messenger RNA splicing [J].
Black, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :291-336
[3]   Alternative splicing: New insights from global analyses [J].
Blencowe, Benjamin J. .
CELL, 2006, 126 (01) :37-47
[4]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[5]  
Chabot B, 2003, Prog Mol Subcell Biol, V31, P59
[6]   DIFFERENTIAL ASF/SF2 ACTIVITY IN EXTRACTS FROM NORMAL WI38 AND TRANSFORMED WI38VA13 CELLS [J].
CHABOT, B ;
FRAPPIER, D ;
LABRANCHE, H .
NUCLEIC ACIDS RESEARCH, 1992, 20 (19) :5197-5204
[7]  
CHABOT B, 1994, RNA PROCESSING PRACT, P1
[8]   De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells -: Dependence on protein phosphatase-1 [J].
Chalfant, CE ;
Rathman, K ;
Pinkerman, RL ;
Wood, RE ;
Obeid, LM ;
Ogretmen, B ;
Hannun, YA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :12587-12595
[9]   FAS activation induces dephosphorylation of SR proteins -: Dependence on the de novo generation of ceramide and activation of protein phosphatase 1 [J].
Chalfant, CE ;
Ogretmen, B ;
Galadari, S ;
Kroesen, BJ ;
Pettus, BJ ;
Hannun, YA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) :44848-44855
[10]   INFLUENCES OF SEPARATION AND ADJACENT SEQUENCES ON THE USE OF ALTERNATIVE 5' SPLICE SITES [J].
CUNNINGHAM, SA ;
ELSE, AJ ;
POTTER, BVL ;
EPERON, IC .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 217 (02) :265-281